Skip to Content


In the US, Cinacalcet (cinacalcet systemic) is a member of the drug class calcimimetics and is used to treat Hypercalcemia of Malignancy, Primary Hyperparathyroidism and Secondary Hyperparathyroidism.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Treatment of hypercalcemia

Calcimimetic agent

Treatment of hyperparathyroidism

Chemical Names

(R)-N-[1-(1-Naphtyl)etyl]-3-[3-(trifluormetyl)phenyl]propan-1-amin (IUPAC)

N-[(1R)-1-(1-naphtyl)etyl]-3-[3-(trifluorometyl)phenyl]propan-1-amine (WHO)

Foreign Names

  • Cinacalcetum (Latin)
  • Cinacalcet (German)
  • Cinacalcet (French)
  • Cinacalcet (Spanish)

Generic Names

  • Cinacalcet (OS: BAN, USAN)
  • AMG 073 (IS: Amgen)
  • Cinacalcet Hydrochloride (OS: USAN, JAN)
  • AMG073 HCl (IS: Amgen)
  • KRN-1493 (IS)

Brand Names

  • Mimpara
    Amgen, Bosnia & Herzegowina; Amgen, Egypt; Amgen, Spain; Amgen, Greece; Amgen, Latvia; Amgen, Oman; Amgen, Turkey
  • Parareg
    Dompé, Lithuania
  • Geser
    Complex Therapeutics, Chile
  • Mimpara
    Amgen, Belgium; Amgen, Czech Republic; Amgen, Germany; Amgen, Finland; Amgen, France; Amgen, United Kingdom; Amgen, Hungary; Amgen, Israel; Amgen, Iceland; Amgen, Lithuania; Amgen, Norway; Amgen, Portugal; Amgen, Romania; Amgen, Serbia; Amgen, Sweden; Amgen, Slovakia; Amgen Austria, Austria; Amgen Dompè, Italy; Amgen Europe, Denmark; Amgen Europe, Netherlands; Amgen Europe, Poland; Amgen Ltd., Ireland; Amgen Mexico, Mexico; Amgen Switzerland, Switzerland
  • Regpara
    Kyowa Hakko Kirin, China; Kyowa Hakko Kirin, Japan; Kyowa Hakko Kirin, South Korea; Kyowa Hakko Kirin, Thailand; Kyowa Hakko Kirin, Taiwan; Kyowa Kirin, Hong Kong
  • Sensipar
    Amgen, Australia; Amgen, Canada; Amgen, New Zealand; Amgen, United States; Batswadi, South Africa


BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.